Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

Detalles Bibliográficos
Autores principales: Iwata, Hiroji, Inoue, Kenichi, Kaneko, Koji, Ito, Yoshinori, Tsugawa, Koichiro, Hasegawa, Ayumi, Nakagawa, Shintaro, Kuratomi, Hiroyasu, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025717/
https://www.ncbi.nlm.nih.gov/pubmed/31950142
http://dx.doi.org/10.1093/jjco/hyz208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025717/
https://www.ncbi.nlm.nih.gov/pubmed/31950142
http://dx.doi.org/10.1093/jjco/hyz208

Ejemplares similares